1 |
Nemati M, Hallaj T, Rezaie J, Rasmi Y. Nitrogen and copper-doped saffron-based carbon dots: Synthesis, characterization, and cytotoxic effects on human colorectal cancer cells. Life Sci 2023;319:121510. [PMID: 36813083 DOI: 10.1016/j.lfs.2023.121510] [Reference Citation Analysis]
|
2 |
Wang S, Deng S, Jin X, Chen W, Wang X, Zhan H, Fang X, Fu J. Dissecting the heterogeneities of the tumor microenvironment between metastatic and nonmetastatic primary colorectal cancer patients by single-cell RNA sequencing. Life Sci 2023;320:121576. [PMID: 36933827 DOI: 10.1016/j.lfs.2023.121576] [Reference Citation Analysis]
|
3 |
Kitsel Y, Cooke T, Sotirchos V, Sofocleous C. Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies. Cancers 2023;15:1679. [DOI: 10.3390/cancers15061679] [Reference Citation Analysis]
|
4 |
Wu M, Wu X, Wang X, Hong X, Liu Y, Lv G, Li C, Pan Z, Zhang R, Chen G. IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases. JPM 2023;13:496. [DOI: 10.3390/jpm13030496] [Reference Citation Analysis]
|
5 |
Kim D, Gupta B, Wong GYM. Prognostic circulating proteomic biomarkers in colorectal liver metastases. Computational and Structural Biotechnology Journal 2023. [DOI: 10.1016/j.csbj.2023.03.011] [Reference Citation Analysis]
|
6 |
Wang R, Jia F, Zhao Z, Du L, Lu L, Xu D, He F. Dachaihu decoction inhibits hypernutrition-induced liver metastasis from colorectal cancer by maintaining the gut vascular barrier. Cancer Pathogenesis and Therapy 2023. [DOI: 10.1016/j.cpt.2023.02.003] [Reference Citation Analysis]
|
7 |
Wensink GE, Bolhuis K, Elferink MAG, Fijneman RJA, Kranenburg O, Borel Rinkes IHM, Koopman M, Swijnenburg RJ, Vink GR, Hagendoorn J, Punt CJA, Roodhart JML, Elias SG. Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases. Br J Surg 2023;110:362-71. [PMID: 36655278 DOI: 10.1093/bjs/znac461] [Reference Citation Analysis]
|
8 |
Li X, Wang Z, Jiao C, Zhang Y, Xia N, Yu W, Chen X, Wikana LP, Liu Y, Sun L, Chen M, Xiao Y, Shi Y, Han S, Pu L. Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3. J Transl Med 2023;21:121. [PMID: 36788538 DOI: 10.1186/s12967-023-03977-z] [Reference Citation Analysis]
|
9 |
Kotelevets L, Chastre E. Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. Cancers (Basel) 2023;15. [PMID: 36831450 DOI: 10.3390/cancers15041107] [Reference Citation Analysis]
|
10 |
Tschoegl M, Gruenberger T. Surgical management of liver metastasis from colorectal cancer. memo 2023. [DOI: 10.1007/s12254-022-00868-9] [Reference Citation Analysis]
|
11 |
Mansur A, Saleem Z, Elhakim T, Daye D. Role of artificial intelligence in risk prediction, prognostication, and therapy response assessment in colorectal cancer: current state and future directions. Front Oncol 2023;13:1065402. [PMID: 36761957 DOI: 10.3389/fonc.2023.1065402] [Reference Citation Analysis]
|
12 |
Ding H, Li X, Zhou L, Cui Z, Meng H, Wang J. [Silenced ANP32A inhibits the growth, invasion and migration of colorectal cancer in vitro via the inactivation of AKT pathway]. Nan Fang Yi Ke Da Xue Xue Bao 2023;43:52-9. [PMID: 36856210 DOI: 10.12122/j.issn.1673-4254.2023.01.07] [Reference Citation Analysis]
|
13 |
Santagata S, Castaldo D, Rea G, Napolitano M, Capiluongo A, D'alterio C, Trotta AM, Ieranò C, Portella L, Tatangelo F, Albino V, Guarino R, Cutolo C, Izzo F, Scala S. Hepatocellular carcinoma (HCC) Tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) Tumor microenvironment.. [DOI: 10.21203/rs.3.rs-2419131/v1] [Reference Citation Analysis]
|
14 |
Zhou H, Wang Y, Zhang Z, Xiong L, Liu Z, Wen Y. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy. Front Genet 2022;13:975404. [PMID: 36699444 DOI: 10.3389/fgene.2022.975404] [Reference Citation Analysis]
|
15 |
Mödl B, Moritsch S, Zwolanek D, Eferl R. Type I and II interferon signaling in colorectal cancer liver metastasis. Cytokine 2023;161:156075. [PMID: 36323190 DOI: 10.1016/j.cyto.2022.156075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
16 |
Zhou H, Liu Z, Zhang Z, Pandey NK, Amador E, Nguyen W, Chudal L, Xiong L, Chen W, Wen Y. Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis. Bioact Mater 2023;24:322-30. [PMID: 36632507 DOI: 10.1016/j.bioactmat.2022.12.023] [Reference Citation Analysis]
|
17 |
Li X, Wang Z, Jiao C, Zhang Y, Xia N, Yu W, Chen X, Wikana LP, Liu Y, Sun L, Chen M, Xiao Y, Shi Y, Han S, Pu L. Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3.. [DOI: 10.21203/rs.3.rs-2391101/v1] [Reference Citation Analysis]
|
18 |
Li T, Yu Q, Liu T, Yang W, Chen W, Jin A, Wang H, Ding L, Zhang C, Pan B, Wang B, Guo W. Development of 14-gene signature prognostic model based on metastasis for colorectal cancer. J Clin Lab Anal 2023;37:e24800. [PMID: 36524971 DOI: 10.1002/jcla.24800] [Reference Citation Analysis]
|
19 |
Sampaio-Ribeiro G, Ruivo A, Silva A, Santos AL, Oliveira RC, Laranjeira P, Gama J, Cipriano MA, Tralhão JG, Paiva A. Extensive Phenotypic Characterization of T Cells Infiltrating Liver Metastasis from Colorectal Cancer: A Potential Role in Precision Medicine. Cancers (Basel) 2022;14. [PMID: 36551555 DOI: 10.3390/cancers14246069] [Reference Citation Analysis]
|
20 |
Ghosh P, Tiwari H, Lakkakula J, Roy A, Emran TB, Rashid S, Alghamdi S, Rajab BS, Almehmadi M, Allahyani M, Aljuaid A, Alsaiari AA, Sharma R, Babalghith AO. A decade's worth of impact: Dox loaded liposomes in anticancer activity. Materials Today Advances 2022;16:100313. [DOI: 10.1016/j.mtadv.2022.100313] [Reference Citation Analysis]
|
21 |
Zheng Z, Wei J, Hou X, Jia F, Zhang Z, Guo H, Yuan F, He F, Ke Z, Wang Y, Zhao L. A High Hepatic Uptake of Conjugated Bile Acids Promotes Colorectal Cancer-Associated Liver Metastasis. Cells 2022;11. [PMID: 36497071 DOI: 10.3390/cells11233810] [Reference Citation Analysis]
|
22 |
Niu Y, Yang W, Qian H, Sun Y. Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated. Cancer Cell Int 2022;22:341. [DOI: 10.1186/s12935-022-02766-w] [Reference Citation Analysis]
|
23 |
Maiorano BA, Parisi A, Maiello E, Ciardiello D. The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer. Life (Basel) 2022;12:1552. [PMID: 36294987 DOI: 10.3390/life12101552] [Reference Citation Analysis]
|
24 |
Lihong Lin, Xiuxiu Zeng, Shanyan Liang, Yunzhi Wang, Xiaoyu Dai, Yuechao Sun, Zhou Wu. Construction of a co-expression network and prediction of metastasis markers in colorectal cancer patients with liver metastasis. J Gastrointest Oncol 2022;13. [PMID: 36388701 DOI: 10.21037/jgo-22-965] [Reference Citation Analysis]
|
25 |
Hewitt DB, Brown ZJ, Pawlik TM. The Role of Biomarkers in the Management of Colorectal Liver Metastases. Cancers 2022;14:4602. [DOI: 10.3390/cancers14194602] [Reference Citation Analysis]
|
26 |
Damato A, Rotolo M, Caputo F, Borghi E, Iachetta F, Pinto C. New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer. Life (Basel) 2022;12:1137. [PMID: 36013315 DOI: 10.3390/life12081137] [Reference Citation Analysis]
|
27 |
Chan LP, Tseng YP, Wang HC, Chien CY, Wu CW, Wang LF, Liang CH. Growth regulated oncogene-α contribute to EMT/MMPs pathway by binding its receptors in head and neck squamous cell carcinoma. Life Sci 2022;306:120791. [PMID: 35817169 DOI: 10.1016/j.lfs.2022.120791] [Reference Citation Analysis]
|